This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 120/19/1845    most recent CIRCULATIONAHA.109.902205v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Francis, G. S. Articles by Wilson Tang, W.H. PubMed PubMed Citation Articles by Francis, G. S. Articles by Wilson Tang, W.H. Related Collections Other heart failure Remodeling Related Article

(Circulation. 2009;120:1845-1846.)
© 2009 American Heart Association, Inc.

Editorial

Early Cardiac Resynchronization Therapy and Reverse Remodeling in Patients With Mild Heart Failure

Is It Time?

Gary S. Francis, MD; W.H. Wilson Tang, MD

From the Cardiovascular Division, University of Minnesota, Minneapolis (G.S.F.), and Cleveland Clinic, Cleveland, Ohio (W.H.W.T.).

Correspondence to Gary S. Francis, MD, University of Minnesota Cardiovascular Division, 420 Delaware St SE, MMC 508, Minneapolis, MN 55455-0341. E-mail franc354@umn.edu

Key Words: Editorials • heart failure • remodeling

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Cardiac resynchronization therapy (CRT) has been shown to consistently improve cardiac performance and exercise capacity, leading to reversal of cardiac remodeling and improvement in survival in patients with advanced heart failure and a significant ventricular conduction delay. The strategy of CRT for the treatment of advanced heart failure was secured in 2005 by the landmark Cardiac Resynchronization in Heart Failure (CARE-HF) study.¹ Recently, 2 studies have extended these observed benefits of CRT to patients with less advanced (New York Heart Association [NYHA] class I/II) signs and symptoms who still fulfilled standard indications for resynchronization therapy. The recently published Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) study demonstrated 34% relative risk reduction in death or heart failure events with CRT and defibrillator (CRT-D) compared with implantable cardioverter-defibrillator alone in 1820 subjects with left ventricular (LV) ejection fraction 30% and QRS duration 130 ms, which was largely driven by reduction in heart failure events and associated with reverse remodeling.² Although the primary end point of a heart failure clinical composite response was not met in the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) trial, observed improvement in the prospectively powered secondary end point of LV end-systolic volume index in the presence of CRT suggests that early implementation of CRT±D in 610 patients with mild heart failure (NYHA class I/II, LV ejection fraction 40% and LV end-diastolic dimension 55 mm by echocardiography, QRS duration 120 ms) may be considered a beneficial strategy.³ The article by St John Sutton . . . [Full Text of this Article]

Related Article:

Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure

Martin St. John Sutton, Stefano Ghio, Ted Plappert, Luigi Tavazzi, Laura Scelsi, Claude Daubert, William T. Abraham, Michael R. Gold, Christian Hassager, John M. Herre, Cecilia Linde on Behalf of the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group
Circulation 2009 120: 1858-1865. [Abstract] [Full Text]